Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares")
-
Shares outstanding
-
125,610,040
-
Total 13F shares
-
63,276,125
-
Share change
-
+1,017,166
-
Total reported value
-
$1,352,112,050
-
Put/Call ratio
-
3.3%
-
Price per share
-
$21.42
-
Number of holders
-
86
-
Value change
-
+$24,497,831
-
Number of buys
-
49
-
Number of sells
-
28
Institutional Holders of Indivior Pharmaceuticals, Inc. - Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") (INDV) as of Q1 2024
As of 31 Mar 2024,
Indivior Pharmaceuticals, Inc. - Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") (INDV) was held by
86 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,276,125 shares.
The largest 10 holders included
Two Seas Capital LP, FMR LLC, SCOPIA CAPITAL MANAGEMENT LP, VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, OAKTREE CAPITAL MANAGEMENT LP, BANK OF AMERICA CORP /DE/, NORGES BANK, TORONTO DOMINION BANK, and BARCLAYS PLC.
This page lists
86
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.